Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Papilledema

• B-Complex: A Nutraceutical SANS Countermeasure
• Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema and CRVO
• Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment o
• Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
• Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF
• Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
• A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
• Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
• Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
• Ozurdex for Macular Edema Post Membrane Peeling
• Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease